ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+9.77%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.23B
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$35.3M |
| 2 |
Johnson & Johnson
JNJ
|
$35.2M |
| 3 |
Microsoft
MSFT
|
$34.6M |
| 4 |
3M
MMM
|
$34.1M |
| 5 |
Exxon Mobil
XOM
|
$33.4M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$70M |
| 2 |
W.R. Berkley
WRB
|
$12.7M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
$11.2M |
| 5 |
Gen Digital
GEN
|
$10.7M |
Sector Composition
| 1 | Technology | 20.43% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.75% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
MRC Global
MRC
$1.28B
| $146K | ﹤0.01% |
+10,710
| New | +$146K |
|
|
NEX
1652
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $145K | ﹤0.01% |
+21,602
| New | +$145K |
|
|
BRSP
1653
BrightSpire Capital
BRSP
$772M
| $144K | ﹤0.01% |
+10,969
| New | +$144K |
|
|
TBIO
1654
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $144K | ﹤0.01% |
17,675
+522
| +3% | +$4.25K |
|
1655
Tronox
TROX
$710M
| $141K | ﹤0.01% |
12,377
+1,978
| +19% | +$22.5K |
|
1656
Trustco Bank Corp NY
TRST
$753M
| $135K | ﹤0.01% |
3,111
+454
| +17% | +$19.7K |
|
|
YJ
1657
Yunji
YJ
$8.42M
| $133K | ﹤0.01% |
726
+15
| +2% | +$2.75K |
|
|
DBD
1658
DELISTED
Diebold Nixdorf Incorporated
DBD
| $133K | ﹤0.01% |
12,600
+1,810
| +17% | +$19.1K |
|
1659
CytomX Therapeutics
CTMX
$376M
| $132K | ﹤0.01% |
15,930
-1,435
| -8% | -$11.9K |
|
|
CHK
1660
DELISTED
Chesapeake Energy Corporation
CHK
| $132K | ﹤0.01% |
801
+62
| +8% | +$10.2K |
|
1661
Resideo Technologies
REZI
$5.32B
| $131K | ﹤0.01% |
+11,009
| New | +$131K |
|
1662
TG Therapeutics
TGTX
$5.11B
| $130K | ﹤0.01% |
+11,682
| New | +$130K |
|
|
PDLI
1663
DELISTED
PDL BioPharma, Inc.
PDLI
| $130K | ﹤0.01% |
39,965
-3,784
| -9% | -$12.3K |
|
1664
Mr. Cooper
COOP
$13.6B
| $129K | ﹤0.01% |
+10,319
| New | +$129K |
|
1665
SiriusPoint
SPNT
$2.19B
| $129K | ﹤0.01% |
12,221
+1,779
| +17% | +$18.8K |
|
|
JMIA
1666
Jumia Technologies
JMIA
$1.09B
| $127K | ﹤0.01% |
18,824
+379
| +2% | +$2.56K |
|
1667
Rigel Pharmaceuticals
RIGL
$742M
| $126K | ﹤0.01% |
5,905
-548
| -8% | -$11.7K |
|
1668
AC Immune
ACIU
$229M
| $124K | ﹤0.01% |
14,611
-3,679
| -20% | -$31.2K |
|
|
CISN
1669
DELISTED
Cision Ltd. Ordinary Share
CISN
| $124K | ﹤0.01% |
12,414
+1,983
| +19% | +$19.8K |
|
1670
Gannett
GCI
$629M
| $123K | ﹤0.01% |
+19,294
| New | +$123K |
|
|
OPTN
1671
DELISTED
OptiNose
OPTN
| $123K | ﹤0.01% |
886
-51
| -5% | -$7.08K |
|
1672
Acco Brands
ACCO
$364M
| $122K | ﹤0.01% |
13,067
+2,085
| +19% | +$19.5K |
|
|
CMO
1673
DELISTED
Capstead Mortgage Corp.
CMO
| $121K | ﹤0.01% |
15,278
+2,196
| +17% | +$17.4K |
|
1674
Corbus Pharmaceuticals
CRBP
$121M
| $120K | ﹤0.01% |
734
-75
| -9% | -$12.3K |
|
1675
Lexicon Pharmaceuticals
LXRX
$396M
| $119K | ﹤0.01% |
28,607
-4,889
| -15% | -$20.3K |
|